Day: May 1, 2025

Kronos Bio Enters into Agreement to Be Acquired by Concentra Biosciences for $0.57 in Cash per Share Plus a Contingent Value Right

Written by Customer Service on May 1, 2025. Posted in Mergers And Acquisitions.

CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) — Kronos Bio, Inc. (“Kronos Bio”) (Nasdaq: KRON), a biotechnology company that has been developing small molecule therapeutics to address cancers and other diseases driven by deregulated transcription, today announced that it has entered into a definitive merger agreement (the “Merger Agreement”) with Concentra Biosciences, LLC ( “Concentra”), whereby Concentra will acquire Kronos Bio for $0.57 in cash per share of Kronos Bio common stock (“Kronos Bio Common Stock”), plus one non-tradeable contingent value right (“CVR”), which represents the right to receive: (i) 50% of the net proceeds in the case of a disposition of the Company’s product candidates known as KB-9558 and KB-7898 that occurs within 2 years following closing; (ii) 100% of the net proceeds in...

Itron Announces First Quarter 2025 Financial Results

Written by Customer Service on May 1, 2025. Posted in Earnings Releases And Operating Results.

LIBERTY LAKE, Wash., May 01, 2025 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating the way utilities and cities manage energy and water, announced today financial results for its first quarter ended March 31, 2025. Key results for the quarter include (compared with the first quarter of 2024):Revenue of $607 million, increased 1%; Gross profit of $217 million, increased 6%; GAAP net income attributable to Itron, Inc. of $65 million, increased $14 million; GAAP diluted earnings per share of $1.42, increased $0.30 per share; Non-GAAP diluted EPS of $1.52, increased $0.28 per share; Adjusted EBITDA of $88 million, increased 15%; and Free cash flow of $67 million, increased $33 million.“First quarter margin expansion and earnings growth were ahead of expectations due to favorable product mix and continued...

InterDigital Announces Financial Results for First Quarter 2025

Written by Customer Service on May 1, 2025. Posted in Earnings Releases And Operating Results.

Revenue, Adjusted EBITDA2 and EPS above top end of guidanceAll-time record annualized recurring revenue4, up 30% YoYCompany reaffirms full year 2025 guidance WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile, video, and AI technology research and development company, today announced results for the quarter ended March 31, 2025. “In the first quarter, we licensed vivo Mobile, a major smartphone vendor, to drive revenue above the top end of our guidance and increase our annualized recurring revenue to a record level. We now have seven of the ten largest smartphone vendors and almost 80% of the entire global smartphone market under license,” commented Liren Chen, President and CEO, InterDigital. “Early in the second quarter, we signed another major license agreement with...

Lloyds Bank PLC: 2025 Q1 Interim Management Statement

Written by Customer Service on May 1, 2025. Posted in Earnings Releases And Operating Results.

LONDON, May 01, 2025 (GLOBE NEWSWIRE) — Lloyds Bank plcQ1 2025 Interim Management Statement1 May 2025 Member of the Lloyds Banking Group FORWARD LOOKING STATEMENTS This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and section 27A of the US Securities Act of 1933, as amended, with respect to the business, strategy, plans and/or results of Lloyds Bank plc together with its subsidiaries (the Lloyds Bank Group) and its current goals and expectations. Statements that are not historical or current facts, including statements about the Lloyds Bank Group’s or its directors’ and/or management’s beliefs and expectations, are forward-looking statements. Words such as, without limitation, ‘believes’, ‘achieves’, ‘anticipates’, ‘estimates’, ‘expects’,...

Form 8.3 – [GLOBALDATA PLC – 30 04 2025] – (CGWL)

Written by Customer Service on May 1, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree GLOBALDATA PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Alpha Modus Holdings Enters into Funding Agreement in Connection with Broadcom Patent Infringement Lawsuit, Secures Option to Acquire Alpha Modus Ventures

Written by Customer Service on May 1, 2025. Posted in Public Companies.

Alpha Modus Ventures sues Broadcomover breakthrough technologies for transporting Fibre Channel data over Ethernet.CORNELIUS, N.C., May 01, 2025 (GLOBE NEWSWIRE) — Alpha Modus Holdings, Inc. (Nasdaq: AMOD), a leader in AI-driven retail technology , today announced it has executed a patent monetization and funding agreement with Alpha Modus Ventures, LLC, the entity that recently filed a patent infringement lawsuit against Broadcom Inc on April 22, 2025. Under the terms of the agreement, Alpha Modus Holdings, Inc. (AMOD) will fund litigation efforts related to the enforcement by Alpha Modus Ventures, LLC (an entity controlled by the CEO of Alpha Modus Holdings, Inc., William Alessi) of U.S. Patent Nos. 11,108,591; 11,303,473; and 11,310,077, which cover breakthrough technologies for transporting Fibre Channel data over...

Form 8.3 – [GLOBALDATA PLC – Opening Disclosure – 30 04 2025] – (CGAML)

Written by Customer Service on May 1, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree GLOBALDATA PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position...

NOTICE OF VIRTUAL ANNUAL GENERAL MEETING OF COINSHARES INTERNATIONAL LIMITED ON 30 MAY 2025

Written by Customer Service on May 1, 2025. Posted in Public Companies.

Notice is hereby given that the Annual General Meeting of CoinShares International Limited (the “Company”) will take place on Friday, 30 May 2025 at 14:00 BST in the form of a hybrid virtual event at 2 Hill Street, St Helier, Jersey, JE2 4UA. The entire Annual General Meeting will be broadcast live online (audio and video) via Wavecast.io and will be open for all shareholders who are entered in the Company’s stock register on the record day of the Annual General Meeting. The exercise of shareholder rights, in particular the exercise of voting rights, requires registration for the meeting in due time and in the proper form and will be performed by poll during the meeting or by granting power of attorney to Company proxies. The location of the Annual General Meeting for the purposes of the minutes is the Company’s registered office, 2 Hill...

Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development – Oncology

Written by Customer Service on May 1, 2025. Posted in Public Companies.

Global expertise in establishing and executing transformative transactions which have led to multiple approved therapeutic products Successful track record across oncology therapeutics including ADCs and antibody therapies ranging from early discovery to pre-clinical/clinical stage 25+ year-career experience bolsters Company’s efforts to address growing, high-value ADC market and maximize opportunities for non-dilutive capital BOSTON and LONDON, May 01, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced the appointment of Mark F. Kubik as Head of Business Development – Oncology. Mr. Kubik is a well-established industry leader whose oncology expertise and transactions record has led to multiple approved...

NANO Nuclear Announces Opening Keynote Presentation and Platinum Sponsorship at the Upcoming Reuters Events: SMR & Advanced Reactor 2025 Conference

Written by Customer Service on May 1, 2025. Posted in Public Companies.

Figure 1NANO Nuclear Energy Inc. Chief Executive Officer to Lead Opening Keynote Presentation at the Reuters Events: SMR & Advanced Reactor 2025 to be held on May 12-13, 2025.New York, N.Y., May 01, 2025 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced that it is the Platinum Sponsor of the upcoming Reuters Events: SMR & Advanced Reactor 2025, to be held in Nashville, Tennessee on 12-13, May 2025. NANO Nuclear Energy Chief Executive Officer James Walker will lead the opening keynote presentation titled, “The Growth of U.S. Advanced Reactors — Wall Street’s Success Story” at 9:00am on May 12th. In the presentation, he will explore how U.S. policy...

Day: May 1, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals